Thermo Fisher Scientific Updates Chromosomal Microarray Analysis Solutions to Comply with IVDR Regulation

Applied Biosystems™ CytoScan™ Dx and Chromosome Analysis Suite (ChAS) Dx software provide complete solution to support cytogenetic testing CARLSBAD, Calif. --  Thermo Fisher Scientific Inc., the world leader in serving science, announced today that the Applied Biosystems™ CytoScan™ Dx Assay and Applied Biosystems™ Chromosomal Analysis Suite (ChAS) Dx software now comply with In Vitro Diagnostic [...]

QIAGEN and Myriad Genetics develop distributable homologous recombination deficiency test for global research and companion diagnostics applications

Next-generation-sequencing-based homologous recombination deficiency (HRD) assay based on QIAGEN’s QIAseq xHYB technology, QIAGEN Digitial Insight solutions, and Myriad’s proprietary, FDA-approved MyChoice CDx® biomarkers QIAGEN to make kit-based HRD test available globally to support research and companion diagnostics development in collaboration with pharmaceutical partners enabling wider adoption and potential clinical indication expansion for MyChoice CDx Project [...]

Biognosys Launches Spectronaut 19 and Presents Advances with Its Research Platforms at the ASMS 2024 Annual Conference

Spectronaut® 19 offers significant improvements in identifications, candidate discovery, scalability for large-scale analysis, and support for novel workflows Novel TrueDiscovery® P2 Plasma Enrichment method offers market-leading performance and superior economics for unbiased, deep plasma proteomics  New TrueTarget® high-throughput LiP-MS workflow enables large-scale drug target deconvolution screening with improved target identification DigitalProteome™ database and Proteoverse™ data exploration tool help [...]

City University of New York Partners with Genestack to Enhance AI readiness of Life Science Data in the Bioconductor Program

City University of New York Partners with Genestack to Enhance AI readiness of Life Science Data in the Bioconductor Program Cambridge, UK – CUNY (City University of New York) and Genestack Ltd are pleased to announce their collaboration aimed at streamlining data curation for the BioConductor program. This innovative partnership brings together the expertise of CUNY [...]

Genedata Expressionist 18.0 Sets New Benchmarks in Biotherapeutic Characterization and GxP-compliant MS Data Review

Latest release expedites review of large data sets and offers new protein characterization functionalities for disulfide bond mapping and top-down mass spectrometry Basel, Switzerland — Genedata, the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced the release of Genedata Expressionist ® 18.0, its platform for streamlining and automating characterization and quality monitoring [...]

Biognosys Launches Groundbreaking P2 Plasma Enrichment Technology for Unbiased, Deep Plasma Proteomics at ASMS 2024

The proprietary P2 Plasma Enrichment method leverages a novel single-well, single particle-type enrichment method to achieve market-leading performance for unbiased, deep mass spectrometry-based plasma proteomics  P2 now offers excellent quantitation and higher throughput for large-cohort biomarker or drug discovery studies, and clinical, epidemiological or population proteomics research P2 Plasma Enrichment is available as a CRO [...]

Quantum-Si Appoints Former Bio-Techne President and CEO, Chuck Kummeth, to serve as independent Chairman of the Board of Directors

BRANFORD, Conn. -- Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced the appointment of Charles (“Chuck”) Kummeth to the role of independent Chairman of the Board, effective May 27, 2024. Mr. Kummeth has over 35 years of leadership experience in Life Sciences most recently as President and CEO of Bio-Techne. During [...]

SOPHiA GENETICS Launches Global Consortium, SOPHiA UNITY, to Accelerate Cancer Research, Drug Development, and Data-Driven Patient Care

New collective intelligence network to enable the most advanced research in oncology in support of precision medicine BOSTON and ROLLE, Switzerland -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a global leader in data-driven medicine, today announced SOPHiA UNITY, a new data-driven consortium designed to accelerate cancer research globally. SOPHiA UNITY aims to bring together leading [...]

Dovetail Genomics Launches AssemblyLink™ Assay, Unlocking Faster Access, More Accurate Genomes for Biodiversity Research

The Dovetail AssemblyLink Assay empowers researchers to assemble high-quality genomes in record time, accelerating efforts to conserve Earth’s incredible biodiversity BOSTON, MASS. -- Dovetail Genomics today announces the Dovetail® AssemblyLink™ Assay, a transformative genomics tool designed to redefine the standards of speed and quality in genomic assembly. Built upon Dovetail’s core LinkPrep™ Technology, the AssemblyLink Assay streamlines [...]

LabVantage Acquires SEIN Infotech South Korea to Expand Environmental Compliance Offerings and Further Growth in APAC Region

LabVantage Acquires SEIN Infotech South Korea to Expand Environmental Compliance Offerings and Further Growth in APAC Region Michel Gerlicher, President of LabVantage International (R), and Jung Moon Lee, CEO of SEIN Infotech (L), seal the acquisition with a handshake. Somerset, NJ – LabVantage Solutions, Inc., the leading provider of laboratory informatics solutions and services, including [...]

Access IBO on Knowledge Center